Lanchi Ventures Leads $42M Series A Financing for Allink Biotherapeutics to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. BEIJING, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecific...
Allink Biotherapeutics Raises $42M Series A Financing to Accelerate Global Development of Bispecific Antibody and ADC Pipeline
The series A investment round secures resources for advancing global Phase I/II clinical programs and orchestrating the company's global footprint expansion. SHANGHAI, Nov. 28, 2024 /PRNewswire/ -- Allink Biotherapeutics, a clinical-stage biotechnology company pioneering next-generation bispecifi...
Li Auto Inc. Listed on the Main Board of HKEX
BEIJING, Aug. 13, 2021 /PRNewswire/ -- Li Auto Inc. ("Li Auto" or the "Company", Nasdaq: LI, HKEX: 2015), an NEV automaker inChina, announced that the Company's Class A ordinary shares ("Shares") began trading on the Main Board of The Stock Exchange of Hong Kong Limited ("HKEX") under the stock c...
Li Auto IPO: Blazing a Different Trail
NEW YORK, July 31, 2020 /PRNewswire/ -- On July 30, 2020, Future Capital
celebrates our angel investment, Li Auto (Ticker: LI)'s successful public
listing on Nasdaq. This is an incredible milestone amidst the current global
economic environment.
